* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Molecular prosthetics for vision restoration based on freely
Computer vision wikipedia , lookup
Premovement neuronal activity wikipedia , lookup
Neuromuscular junction wikipedia , lookup
Biological neuron model wikipedia , lookup
Neural oscillation wikipedia , lookup
Neural modeling fields wikipedia , lookup
Haemodynamic response wikipedia , lookup
Neurotransmitter wikipedia , lookup
Holonomic brain theory wikipedia , lookup
Dendritic spine wikipedia , lookup
Neuroanatomy wikipedia , lookup
Synaptic gating wikipedia , lookup
Pre-Bötzinger complex wikipedia , lookup
Neuroplasticity wikipedia , lookup
Synaptic noise wikipedia , lookup
Nervous system network models wikipedia , lookup
Spike-and-wave wikipedia , lookup
Molecular neuroscience wikipedia , lookup
Clinical neurochemistry wikipedia , lookup
Synaptogenesis wikipedia , lookup
Optogenetics wikipedia , lookup
Channelrhodopsin wikipedia , lookup
Metastability in the brain wikipedia , lookup
Chemical synapse wikipedia , lookup
Nonsynaptic plasticity wikipedia , lookup
Nanoprobes and nanoswitches group Group leader: Pau Gorostiza Molecular prosthetics for vision restoration based on freely-diffusible and covalently bound photoswitches Light-regulated drugs allow remotely photoswitching biological activity and enable plausible therapies based on small molecules. We develop efficient compounds to manipulate neuronal activity for fundamental and therapeutic purposes. In the first case, simultaneous photocontrol of synaptic receptors and fluorescence imaging of neuronal activity in vivo will allow studying synaptic plasticity from the single dendritic spine level up to the whole brain. Regarding therapeutic applications, the compounds developed will be used to impart light sensitivity to remaining inner retinal neurons in animal models of degenerated retina. As small molecules, our photoswitches can be subject to optimization in well-established pharmacological and safety assays, and can be tested in non-genetic model organisms of the disease. Thus they have the potential to become preclinical candidate drugs to be transferred to the pharmaceutical industry. The development, optimization and applications of photoswitches in several animal models offers outstanding opportunities as a fundamental tool to photomanipulate synaptic plasticity in vivo, as well as a small-molecule therapeutic approach to vision restoration. www.ibecbarcelona.eu